Metabolism and Cell Signaling Laboratory
Basic/translational research
Spanish National Cancer Research Center (CNIO)
·Madrid ·

At the CNIO’s Metabolism and Cell Signaling laboratory we study the connection between nutrient excess and cancer. In particular, pancreatic cancer has a strong association with an elevated body mass index, and we still largely do not know why this association exists. Using mouse models, together with biochemical and cellular tools, our group focuses on understanding how overweight leads to aberrant activation of the immune system, chronic inflammation and cellular alterations in the pancreatic epithelium favor cancer development.

Main publications in pancreatic cancer:

  1. Ortega-Molina A, Lebrero-Fernández C, Sanz A, et al. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Rep. 2021 Jul 13;36(2):109372. doi: 10.1016/j.celrep.2021.109372. PMID: 34260908; PMCID: PMC8355512.
  2. de la Calle Arregui C, Plata-Gómez AB, Deleyto-Seldas N, et al. Limited survival and impaired hepatic fasting metabolism in mice with constitutive Rag GTPase signaling. Nat Commun. 2021 Jun 16;12(1):3660. doi: 10.1038/s41467 021-23857-8. PMID: 34135321; PMCID: PMC8209044.
  3. Ortega-Molina A, Deleyto-Seldas N, Carreras J, et al. Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR. Nat Metab. 2019 Aug;1(8):775-789. doi: 10.1038/s42255-019-0098-8. Epub 2019 Aug 19. PMID: 31579886; PMCID: PMC6774795.
Alejo Efeyan
Yurena Vivas

Principal Investigator

Group members

  • Alejo Efeyan
  • Yurena Vivas
More information

Other groups

Virology and Cellular Immunology Group – Carmen Aguilar

Our group at IrsiCaixa focuses on the development of innovative therapeutic strategies against solid tumors, with a particular emphasis on pancreatic cancer. The group integrates immunological, molecular, and translational approaches to design and evaluate cancer...

Neoantigens and Vaccines Against Cancer – Núria de la Iglesia

The Neoantigens and Cancer Vaccines group (NeoVaCan) is part of the IrsiCaixa Institute for Research on Immunopathologies, a center dedicated to the study of diseasesrelated to the immune system, ranging from viral infections, such as HIV or SARS-CoV-2, to cancer. Our...

Angiogenesis Group – Alfredo Martínez Ramírez

The Angiogenesis Group is part of the Oncology Area of the Biomedical Research Center of La Rioja (CIBIR), located in Logroño, Spain. As the name implies, the Angiogenesis Group focuses on the process of angiogenesis in relation to cancer and other relevant diseases...

See all groups